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Abstract 
Purpose: The Sepsis-3 consensus task force defined sepsis as life-threatening organ dysfunction caused by dys-
regulated host response to infection. However, the clinical criteria for this definition were neither designed for nor 
validated in children. We validated the performance of SIRS, age-adapted SOFA, quick SOFA and PELOD-2 scores as 
predictors of outcome in children.
Methods: We performed a multicentre binational cohort study of patients < 18 years admitted with infection to 
ICUs in Australia and New Zealand. The primary outcome was ICU mortality. SIRS, age-adapted SOFA, quick SOFA 
and PELOD-2 scores were compared using crude and adjusted area under the receiver operating characteristic curve 
(AUROC) analysis.
Results: Of 2594 paediatric ICU admissions due to infection, 151 (5.8%) children died, and 949/2594 (36.6%) patients 
died or experienced an ICU length of stay ≥ 3 days. A ≥ 2-point increase in the individual score was associated with 
a crude mortality increase from 3.1 to 6.8% for SIRS, from 1.9 to 7.6% for age-adapted SOFA, from 1.7 to 7.3% for 
PELOD-2, and from 3.9 to 8.1% for qSOFA (p < 0.001). The discrimination of outcomes was significantly higher for SOFA 
(adjusted AUROC 0.829; 0.791–0.868) and PELOD-2 (0.816; 0.777–0.854) than for qSOFA (0.739; 0.695–0.784) and SIRS 
(0.710; 0.664–0.756).
Conclusions: SIRS criteria lack specificity to identify children with infection at substantially higher risk of mortality. We 
demonstrate that adapting Sepsis-3 to age-specific criteria performs better than Sepsis-2-based criteria. Our findings 
support the translation of Sepsis-3 into paediatric-specific sepsis definitions and highlight the importance of robust 
paediatric organ dysfunction characterization.
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Introduction
While the prevalence and mortality of paediatric sepsis 
has become comparable to figures reported in adult ICUs 
in high-income countries [1–3], defining sepsis in the 
absence of a gold standard remains a challenge [4]. Fol-
lowing the 2001 consensus statement of the Society of 
Critical Care Medicine, paediatric sepsis was defined as 
infection in the presence of at least two out of four cri-
teria of the systemic inflammatory response syndrome 
(SIRS) [5, 6]. The 2005 Consensus definition for paediat-
ric sepsis maintained the requirement for SIRS, provid-
ing further specification on organ failure definitions [6]. 
The validity of SIRS criteria to identify and risk-stratify 
patients with sepsis has been challenged in adults, where 
insufficient sensitivity and specificity were demonstrated 
[7, 8]. While tachycardia and tachypnoea represent adap-
tive mechanisms commonly seen in febrile childhood 
infections, including diseases with near-zero mortality 
(e.g. bronchiolitis [9]), the face, and construct validity 
and sensitivity of SIRS criteria have not been studied in 
large cohorts of critically ill children.
The recent Sepsis-3 consensus definition emphasized 
that sepsis is differentiated from uncomplicated infection 
by the presence of life-threatening organ dysfunction as 
a result of a dysregulated host response to infection [10]. 
The Delphi process, systematic reviews, and development 
and validation cohorts leading to Sepsis-3 were based on 
adult populations and the task force recognized “the need 
to develop similar updated definitions for pediatric popu-
lations” [11]. However, current paediatric sepsis defini-
tions remain essentially based on Sepsis-2, representing a 
major obstacle towards research, benchmarking, coding, 
and quality monitoring [11, 12]. The operationalization of 
clinical criteria to identify individuals meeting outcomes 
consistent with sepsis in Sepsis-3 is based on the Sequen-
tial Organ Failure Assessment (SOFA) score, however 
neither SOFA nor quick SOFA (qSOFA) were developed 
for children.
We hypothesized that in children admitted to ICU with 
infection, the presence of organ dysfunction would better 
identify patients at substantially higher mortality in com-
parison to the presence of ≥  2 SIRS criteria. We com-
pared the performance of SIRS criteria with measures of 




Multicentre binational cohort study of patients < 18 years 
admitted to ICUs in Australia and New Zealand. The 
study was approved by the Human Research and Ethics 
Committee. Patients were eligible if they had presence 
of suspected or proven infection [7, 8] at admission to 
an adult or combined adult/paediatric ICU which con-
tributed data to the ANZICS Adult Patient Database. 
The ANZICS Adult Patient Database captures prospec-
tive information on more than 90% of all adult and mixed 
adult/paediatric ICU admissions in Australia and New 
Zealand, but does not include the specialized paediat-
ric ICUs which contribute to the separate ANZPIC reg-
istry (Supplementary Material). For patients that were 
transferred to a PICU, cases were followed through the 
Australian and New Zealand Paediatric Intensive Care 
Registry [2, 13].
Outcomes and definitions
In-hospital mortality was defined as the primary out-
come. The composite secondary outcome was defined as 
in-hospital mortality or ICU length of stay of 3  days or 
longer [8, 14].
Physiological parameters on cardiorespiratory, neuro-
logic, hepatic, renal and haematological organ dysfunc-
tion were prospectively recorded, capturing the highest 
and lowest value recorded during the first 24  h of ICU 
admission. SIRS criteria, pediatric logistic organ dys-
function score-2 (PELOD-2), SOFA, and qSOFA were 
calculated (Supplementary Table 1). Age-specific cut-offs 
to define SIRS criteria, and definitions for severe sepsis 
were applied as per the 2005 Pediatric Sepsis Consensus 
statement and the correction provided in a subsequent 
Take‑home message 
The SIRS criteria lack specificity to identify children with 
infection at substantially higher risk of mortality. Adapt-
ing Sepsis-3 criteria using age-specific SOFA scores 
performs better than Sepsis-2-based criteria. Our find-
ings support the need to translate Sepsis-3 criteria into 
paediatric-specific sepsis definitions and highlight the 
importance of robust organ dysfunction characteriza-
tion in children with infections.
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author’s reply [6, 15]; paediatric SIRS was defined as pres-
ence of ≥ 2 SIRS criteria, one of which must be abnormal 
temperature or WCC. All PELOD-2 items, except for 
pupillary dilatation and serum lactate levels, were avail-
able in the database to allow calculation of a PELOD-2 
ranging from zero (best) to 22 (worst) [16]. Given the 
absence of age-specific SOFA definitions, we developed 
an age-adapted SOFA by defining increasing severity of 
cardiovascular and renal dysfunction using the PELOD-2 
cut-offs for mean arterial blood pressure and serum cre-
atinine increase. qSOFA was defined as a score composed 
of three binary variables (tachypnoea, altered menta-
tion, hypotension) [10]. Age-specific qSOFA scores were 
defined by applying age-specific cut-offs for respiratory 
rate and systolic blood pressure, respectively, as per the 
corrected 2005 Pediatric Sepsis definitions [6, 15].
Statistics
Data are presented as percentages and numbers or means 
with standard deviation. We measured the discrimination 
of each score using the area under the receiver operating 
characteristic curve (AUROC). The sensitivity, specificity, 
negative predictive value (NPV) and positive predictive 
value (PPV) was calculated for each score. A baseline risk 
model was developed to reflect the underlying risk of a 
patient developing the primary and secondary outcomes 
using available information at the time of ICU admis-
sion not contained in any of the scores. Univariate mixed 
effects logistic regression models, with a random effect 
for each site, were used to assess associations between 
patient factors and the primary outcome. Variables with 
associations p < 0.2 where considered for inclusion in a 
multivariable model. The same model was applied to the 
secondary outcome.
Sensitivity analyses were performed by using age- and 
sex-specific systolic blood pressure cut-offs based on the 
5th percentile previously validated in children with sep-
sis [13, 17], and by using systolic blood pressure cut-offs 
used to define arterial hypotension in the corrected 2005 
consensus definition [6, 15]. Analyses were conducted 
Table 1 Distribution of signs meeting SIRS criteria in children admitted to ICU with infection, according to primary out‑
come (mortality) and secondary outcome (mortality or ICU stay ≥ 3 days)
LOS intensive care unit length of stay, SIRS systemic inflammatory response syndrome
SIRS criterion met, N (%) All patients Primary outcome (mortality) Secondary outcome 
(mortality or ICU 
LOS ≥ 3 days)
N % N % N %
Abnormal heart rate 1295 57.0 108 8.3 593 45.8
Increased respiratory rate 1896 83.5 106 5.6 700 36.9
Abnormal temperature 1091 48.0 89 8.2 509 46.7
 High temperature 669 29.5 47 31.1 337 35.5
 Low temperature 487 21.4 49 32.5 211 22.2
Abnormal white-cell count 1342 59.1 103 7.7 574 42.8
 High WCC 1106 48.7 57 37.8 446 47
 Low WCC 248 10.9 46 30.5 135 14.2
2 or More SIRS criteria
 Not present 413 18.2 13 3.2 120 29.1
 Present 1858 81.8 126 6.8 758 40.8
Paediatric SIRS (2 or more SIRS criteria, one of which must be abnormal temperature or white cell count)
 Not present 596 26.2 21 3.5 176 29.5
 Present 1675 73.8 118 7.0 702 41.9
Number of SIRS criteria present All patients Primary outcome (mortality) Secondary outcome (mortal‑
ity or ICU LOS ≥ 3 days)
N % N % (95% CI) N % (95% CI)
0 57 2.5 2 3.5 (0.04–12.1) 19 33.3 (21.4–47.1)
1 356 15.6 11 3.1 (1.6–5.5) 101 28.4 (23.7–33.4)
2 704 31.0 30 4.3 (2.9–6.0) 230 32.7 (29.2–36.3)
3 756 33.3 49 6.5 (4.8–8.5) 297 39.3 (35.8–42.9)
4 398 17.5 47 11.8 (8.8–15.4) 231 58.0 (53.0–62.9)
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using Stata (version 14.0, Stata Corp, College Station, TX, 
USA). p values < 0.05 were considered significant.
Results
Study population
Between 2000 and 2016, 2,715 patients aged  <  18  years 
were admitted to an adult or mixed ICU because of infec-
tion and recorded in the ANZICS Adult Patient Data-
base. 121 episodes were excluded: one (0.04%) duplicated 
record, 49 (1.8%) patients  >  16  years were transferred 
alive to another adult ICU with unknown outcome and 
71 (2.6%) had missing outcome data. A final cohort of 
2594 paediatric ICU admission encounters due to infec-
tion with known outcomes were identified, with a median 
age of 13  years (IQR 1–16). 151 (5.8%) children died in 
hospital and 949 (36.6%) died in hospital or experienced 
an ICU length of stay of 3 days or more (Supplementary 
Table  2). 1510 (58.3%) were classified as severe sepsis. 
The mortality in this group was 7.4% and the secondary 
outcome was met in 43.9% of patients with severe sepsis.
SIRS criteria
Of all 2594 episodes, SIRS data was incomplete in 323 
(12.4%). 57/2271(2.2%) children did not present with 
any SIRS criteria during the first 24 h of ICU admission, 
356 (15.6%) met one SIRS criterion, 1858/2271 (81.8%) 
fulfilled at least two SIRS criteria, and 1675 (73.8%) met 
paediatric SIRS (Table 1, Fig. 1). Mortality increased from 
3.1% in presence of < 2 SIRS criteria to 6.8% if ≥ 2 SIRS 
criteria were present (between-group difference, 3.6%, 
95% CI 1.6–5.7, p = 0.005, Fig. 2, Supplementary Figs. 1 
and 2). Using patients with  <  2 SIRS criteria as a refer-
ence, the relative increase in the primary and secondary 
outcomes was not significant for 2 SIRS criteria, but was 
significant for 3 SIRS criteria (primary outcome OR 1.94, 
95% CI 1.02–3.70); secondary outcome OR 1.46, 95% CI 
1.12–1.92), and for 4 SIRS criteria (primary outcome OR 
3.31, 95% CI 1.72–6.37; secondary outcome OR 2.97, 95% 
CI 2.19–4.03).
Using models adjusted for baseline risk, the relative 
odds of death increased in the presence of paediatric 
SIRS (OR 1.83, 95% CI 1.13–2.99, p = 0.015), or the pres-
ence of any ≥ 2 SIRS criteria (OR 2.00, 95% CI 1.10–3.64, 
p = 0.023). The relative odds of the secondary outcome 
increased in the presence of paediatric SIRS (OR 1.54, 
95% CI 1.25–1.90, p < 0.001), and in the presence of ≥ 2 
SIRS criteria (OR 1.50, 95% CI 1.21–1.85, p  <  0.001). 
Overall, each additional SIRS criterion was associated 
with a 50% increase in the relative odds for the primary 
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Fig. 1 Distribution of patients < 18 years with infection by SIRS criteria, PELOD-2 score, SOFA and qSOFA score measured during the first 24 h of ICU 
admission
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38% increase for the secondary outcome (OR 1.38, 95% 
CI 1.27–1.52, p < 0.001).
SOFA, PELOD‑2 and qSOFA
1690 (74.2%) of infected patients had an age-adapted 
SOFA score of ≥ 2 (Fig. 1). The mortality increased from 
1.9 to 7.6% if the SOFA score was ≥  2 (between-group 
difference, 5.7%, 95% CI 4.0–7.4, p  <  0.001, Fig.  2). The 
risk of the secondary outcome increased from 17.6 to 
46.1% in those with a SOFA score of ≥ 2 (between-group 
difference, 28.5%, 95% CI 24.7–32.4, p  <  0.001, Supple-
mentary Fig. 2).
When assessing organ dysfunction using PELOD-2, 
a score of ≥  8 performed best in identifying patients at 
higher mortality: There were 374 (14.4%) children with 
a PELOD-2 score ≥ 8, with a mortality of 22.2% (versus 
3.0% in those with scores < 8, p < 0.001) and a second-
ary outcome incidence of 79.4% (versus 20.6%, p < 0.001). 
Among children with a PELOD-2 score of ≥ 2, mortality 
was 7.3% (versus 1.7% in those with scores < 2, p < 0.001) 
and the secondary outcome occured in 43.8% (versus 
17.2%, p < 0.001).
For those who had a qSOFA (altered mentation, arte-
rial hypotension, and tachypnea) score of ≥ 2, mortality 
was 8.1% (97/1200) in comparison to 3.9% (41/1059) with 
a qSOFA  <  2 (between-group difference, 4.2%; 95% CI 
2.3–6.1, p < 0.001).
Comparison of SIRS, severe sepsis, SOFA, PELOD‑2 
and qSOFA
There were significant differences in discrimina-
tion of both primary and secondary outcomes in 
crude and adjusted analyses (p  <  0.001). For the pri-
mary outcome, discrimination was highest for SOFA 
(AUROC  =  0.829) which was significantly higher 
than SIRS (AUROC  =  0.727, p  <  0.001), severe 
sepsis (AUROC  =  0.711, p  <  0.001), and qSOFA 
(AUROC  =  0.739, p  <  0.001), though not significantly 
higher than PELOD-2 (AUROC  =  0.816, p  =  0.970). 
For the secondary outcome, discrimination was high-
est for PELOD-2 (AUROC  =  0.771), which was sig-
nificantly higher than SIRS (AUROC  =  0.676, 
p  <  0.001), severe sepsis (AUROC =  0.677, p  <  0.001), 
qSOFA (AUROC  =  0.682, p  <  0.001), and SOFA 
(AUROC = 0.751, p < 0.001) (Table 2, Fig. 3, Supplemen-
tary Table 3). The best binary performance for PELOD-2 
was using a cutpoint score of ≥ 8, resulting in an adjusted 
AUROC for in-hospital mortality of 0.812 (95% CI 




















































Fig. 2 Mortality by SIRS criteria, PELOD-2 score, SOFA and qSOFA score measured during the first 24 h of ICU admission in patients < 18 years 
admitted with infection
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Sensitivity analyses were performed using different 
adjusted models, and based on different thresholds to 
define qSOFA, which resulted similar (Online Supple-
mentary Table 3).
Discussion
In this multicentre cohort of 2594 children 
aged < 18 years admitted to ICU with infection, we exter-
nally validated and assessed the discriminatory capaci-
ties of SIRS, severe sepsis, SOFA, PELOD-2, and qSOFA. 
We observed superior prognostic accuracy of SOFA and 
PELOD-2, both for in-hospital mortality and for the com-
posite outcome of in-hospital mortality or ICU length of 
stay of ≥ 3 days, in comparison with SIRS, severe sepsis, 
or qSOFA. SIRS lacked specificity to identify children 
with infection at substantially higher mortality risk.
Key features underlying the Sepsis-3 consensus defi-
nition relate to the differentiation of sepsis from non-
life-threatening infection, operationalization of the 
definition, and establishment through a data-driven 
process using large cohorts [18]. In contrast, paediat-
ric Sepsis-2 definitions focus on systemic inflammation, 
applying non-validated criteria commonly seen outside 
sepsis, and have specific requirements for individual 
organ dysfunctions, attributing more weight to cardio-
vascular or respiratory organ dysfunction [19, 20]. The 
paradigm of SIRS as a feature of paediatric sepsis has 
been maintained for two decades, but neither SIRS nor 
the particular organ dysfunction criteria—which over-
lap with multiorgan dysfunction—to define severe sep-
sis in children have been externally validated in large 
ICU cohorts. Previous studies reported that SIRS crite-
ria are met in > 90% of febrile children presenting to ED, 
of which < 5% require ICU admission [21]. We demon-
strate that ≥ 2 SIRS criteria are present in 81.8% of pae-
diatric patients admitted to ICU with infection, resulting 
in poor specificity and poor positive predictive value to 
capture patients at risk for adverse outcomes. While 
each additional SIRS criterion was associated with an 
increase in the relative odds of the primary, and second-
ary outcomes, significance was only reached when 3 or 
4 SIRS criteria were present. Furthermore, the sensitivity 
of ≥ 2 SIRS criteria to discriminate in-hospital mortality 
was inferior to an incremental increase by ≥ 2 points in 
Table 2 Crude and adjusted AUROCs for discrimination characteristics of SIRS, SOFA, PELOD‑2 and qSOFA on ICU admis‑
sion in patients < 18 years with suspected or confirmed infection
Predictor Definition Primary outcome: Hospital mortality Secondary outcome: mortality and/or ICU 
LOS ≥ 3 days
Area under the curve Area under the curve
Crude Adjusted Crude Adjusted
SIRS SIRS N criteria 0.630 (0.583–0.676) 0.727 (0.682–0.772) 0.603 (0.580–0.626) 0.676 (0.654–0.699)
SIRS ≥ 2 criteria (paediatric) 0.559 (0.528–0.591) 0.710 (0.664–0.756) 0.551 (0.533–0.568) 0.664 (0.641–0.687)
SIRS ≥ 2 criteria (any) 0.563 (0.532–0.594) 0.708 (0.664–0.751) 0.565 (0.548–0.582) 0.673 (0.652–0.694)
Severe sepsis 2005 consensus 0.586 (0.550–0.622) 0.711 (0.667–0.755) 0.592 (0.574–0.611) 0.677 (0.656–0.698)
SOFA SOFA score 0.782 (0.738–0.827) 0.829 (0.791–0.868) 0.731 (0.710–0.752) 0.751 (0.730–0.772)
SOFA ≥ 2 criteria 0.595 (0.571–0.620) 0.743 (0.701–0.785) 0.615 (0.599–0.631) 0.702 (0.689–0.723)
PELOD PELOD score 0.774 (0.731–0.818) 0.816 (0.777–0.854) 0.750 (0.730–0.770) 0.771 (0.752–0.790)
PELOD ≥ 2 criteria 0.601 (0.578–0.625) 0.726 (0.685–0.767) 0.613 (0.597–0.629) 0.694 (0.673–0.715)
PELOD ≥ 8 criteria 0.719 (0.679–0.759) 0.812 (0.774–0.851) 0.633 (0.618–0.649) 0.744 (0.724–0.764)
qSOFA qSOFA score 0.638 (0.588–0.687) 0.739 (0.695–0.784) 0.597 (0.575–0.620) 0.682 (0.659–0.704)
qSOFA ≥ 2 criteria 0.591 (0.552–0.631) 0.722 (0.677–0.767) 0.581 (0.560–0.601) 0.679 (0.656–0.701)
Predictor Definition Primary outcome: hospital mortality
Sensitivity (%) Specificity (%) Negative predictive value (%) Positive predictive value (%)
SIRS SIRS ≥ 2 criteria (pediatric) 84.9 27.0 96.5 7.0
SIRS SIRS ≥ 2 criteria (any) 83.4 29.1 96.6 6.8
Severe sepsis 2005 consensus 74.5 42.7 96.5 7.4
SOFA SOFA ≥ 2 criteria 92.1 26.9 98.1 7.6
qSOFA qSOFA ≥ 2 criteria 70.3 48.0 96.1 8.1
PELOD PELOD ≥ 2 criteria 91.9 28.3 98.3 7.3
PELOD PELOD ≥ 8 criteria 88.1 55.7 97.0 22.2
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SOFA or PELOD-2, challenging the common notion that 
SIRS has excellent sensitivity for sepsis. Our findings are 
supported by a study in critically ill adults, demonstrating 
shortcomings in sensitivity, specificity, and validity of ≥ 2 
SIRS criteria to define sepsis [7]. The limited utility if 
SIRS is further illustrated by substantial differences when 
applying Sepsis-3 versus Sepsis-2 criteria to infected chil-
dren [11]. In a recent study on children with bloodstream 
infection, 30-day mortality was 1% in the presence of 
bacteraemia and SIRS without organ dysfunction, but 
increased to 17% when organ dysfunction was present 
[22]. Hence, our findings support abandoning SIRS since 
operationalising inflammation performs inferior to oper-
ationalising organ dysfunction when predicting death or 
prolonged ICU stay as outcomes.
Both age-adapted SOFA and PELOD-2 were superior 
to SIRS in identifying patients with infection at greater 
risk of mortality. Given the limited evidence on optimal 
blood pressure thresholds [23, 24], and to avoid overfit-
ting of models, we applied the validated PELOD-2 age-
specific cut-offs for cardiovascular and renal dysfunction, 
which may partially account for the similar performance 
observed between SOFA and PELOD-2 [25]. When 
simplifying the discrete scores (SIRS, SOFA, PELOD-
2, qSOFA) to binary categorizations, PELOD  ≥  8 per-
formed best. Notably, Sepsis-3 defined an increase in 
SOFA by ≥ 2 points based on the a priori requirement to 
identify presence of ≥ 1 (new) organ dysfunction to char-
acterize sepsis, and not by post hoc derivation of opti-
mal cut-offs. While a PELOD-2 ≥ 2 will capture patients 
with ≥ 1 organ dysfunction, PELOD ≥ 8 performed best 
in our study but such scores will predominantly reflect 
multiorgan dysfunction. Our findings support the opera-
tionalization of clinical criteria to paediatric patients with 
sepsis [10] and are highly comparable to a large exter-
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Fig. 3 Comparison of area under the receiver operating characteristic curves (AUROCS) to discriminate in-hospital mortality (primary outcome) and 
in-hospital mortality or ICU length of stay of 3 days or more (secondary outcome) for SIRS criteria, SOFA, qSOFA, and PELOD scores at ICU admission. 
AUROCs are shown for primary (a, c) and secondary (b, d) outcomes using crude (a, b) and adjusted (c, d) models
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the same database [8]. Leclerc and colleagues assessed 
PELOD-2 in 862 children with infection recruited in the 
original PELOD cohort and reported a high in-sample 
performance [23]. Our findings are further supported by 
a recent single centre PICU study including patients up to 
21 years which tested a paediatric SOFA adaptation [26] 
based on the same PELOD-2 cut-offs for arterial hypo-
tension and renal dysfunction but applying a more granu-
lar score increase, resulting in excellent performance. In 
contrast to the paper by Matics et al. [26] which did not 
report on SIRS or severe sepsis, we analyzed multicentre 
data of patients  <  18  years, using mortality as the pri-
mary and mortality and/or PICU length of stay ≥ 3 days 
as the composite secondary outcome, and applied crude 
and adjusted analyses using similar methodology to adult 
Sepsis-3 validation cohorts [8].
qSOFA has been proposed as a screening tool in adults 
with infection, prompting assessment for evidence of 
organ dysfunction on hospital floors or in the ED [10]. 
In our study, the performance of our adapted qSOFA 
score to identify children who subsequently died or 
had prolonged length of stay was only moderate, which 
potentially could reflect the use of ventilation, sedation, 
and inotropes in ICU, altering respiratory rate, blood 
pressure, and GCS. In comparison, other PICU sepsis 
scores and paediatric Early Warning Tools have reported 
AUROCs of > 0.80 [12, 27]. Specific features of paediat-
ric sepsis and septic shock [28], such as late development 
of arterial hypotension and a higher proportion of ful-
minant presentations [12, 22, 29, 30], warrant improved 
rapid identification of infected paediatric patients with 
organ dysfunction [30] across emergency department, 
hospital ward, and ICU settings. Given the high pro-
portion of patients with organ dysfunction (74% with 
SOFA ≥  2) in our cohort, future studies are needed to 
test the discriminatory performance in cohorts of lower 
average acuity.
The key strengths of this study relate to the application 
of stringent data-driven validation procedures to allow 
comparison of the prognostic accuracy of SIRS, severe 
sepsis, SOFA, PELOD-2 and qSOFA. Moreover, given 
the limitations of using mortality as an outcome, analy-
ses included the composite outcome of mortality or ICU 
length of stay of 3 days or longer, aligned with adult Sep-
sis-3 studies [8, 13]. We deliberately did not restrict the 
study to admissions coded as sepsis but instead included 
all children admitted to ICUs with suspected and con-
firmed infection. Diagnoses were based on assessment by 
trained ICU specialists and not administrative coding.
Our study carries several limitations. First, it is based 
on a binational prospective dataset of adult and mixed 
adult-paediatric ICUs, whereas the main PICUs contrib-
ute to a different registry, which may have led to selection 
bias. In contrast to the paediatric ANZPIC registry, the 
ANZICS APD has been prospectively collecting data on 
SIRS, APACHE and SOFA score in patients admitted to 
the contributing units which ensured consistent practices 
of organ dysfunction assessment and data monitoring. 
Due to the high centralization of PICU services in Aus-
tralia and New Zealand, it is common for critically ill 
children outside large metropolitan areas to be admitted 
to mixed ICUs. In the present study, 149 (5.8%) children 
required secondary interhospital transfer to a PICU, all of 
which were tracked to capture the primary and secondary 
outcome. Second, capturing the worst parameters within 
the first 24 h of ICU admission may not capture peak dis-
ease severity, resulting in lower performance of the scores 
[26]. However, prediction requires early assessment 
by definition and the passage of time is associated with 
competing risk bias due to death or discharge from ICU. 
In a recent study on a different cohort of septic children 
admitted to specialized PICUs we have demonstrated 
that a small set of clinical variables available within the 
first hour of PICU admission allows to establish robust 
severity stratification for paediatric sepsis mortality [12]. 
Third, although data collection for this binational ICU 
registry had been monitored using regular quality con-
trols and mandatory audits, data had not been primarily 
captured for sepsis studies. Fourth, the SOFA score was 
modified as detailed information on vasopressor type and 
dose was not consistently available. Finally, two items of 
the PELOD score, including pupil size and serum lactate 
levels, were not available in the database, which may have 
reduced the performance of PELOD. Several studies have 
identified lactate as one of the best predictors of paediat-
ric sepsis severity [12, 31, 32].
In conclusion, the two SIRS variables based sepsis cri-
teria had poor specificity and diagnostic performance 
to discriminate children with infection at substantially 
higher mortality risk. In contrast, SOFA and PELOD-2 
had significantly greater prognostic accuracy for in-hos-
pital mortality. Our findings indicate that age-specific 
translation of Sepsis-3 definitions to critically ill children 
using validated measures of organ dysfunction should be 
considered in the next revision of paediatric sepsis defi-
nitions. In contrast, the performance of qSOFA to iden-
tify patients with organ dysfunction at risk for worse 
outcomes was poor, and may not be of sufficient clinical 
value to be recommended as a screening tool for paediat-
ric age groups within the ICU.
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